• Users Online: 79
  • Print this page
  • Email this page
Year : 2018  |  Volume : 11  |  Issue : 4  |  Page : 175-183

Advancements in the treatment of degenerative disc disease

Department of Bioengineering, University of Toledo, Toledo, Ohio, USA

Correspondence Address:
Prof. Hassan Serhan
Department of Bioengineering, University of Toledo, Toledo, Ohio
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/HMJ.HMJ_85_18

Rights and Permissions

Low back pain is number one reason for disability in patients under the age of 45 year and the number two reason to see a doctor after flue in the USA. Early intervention for the treatment of patients with Degenerative Disc Disease (DDD) using regenerative medicine or ultra-minimal invasive approaches have gained traction over the past 20 years as alternatives to invasive, costly, and complicated surgical interventions. This review article discusses the pathophysiology of DDD and summarizes the literature encompassing the use of biologic-based therapies for DDD. Articles and patents published in the past 40 years were reviewed, cell-based, bimolecular or gene therapies, as well as companies investigating the utility of allogeneic and tissue-engineered intervertebral discs were included. Additionally, published and unpublished ongoing clinical trials were also included. These exciting non-invasive therapies have encouraging initial positive results across multiple strategies paving the road for a potentially thriving regenerative techniques and increase in the number of DDD clinical trials.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded496    
    Comments [Add]    
    Cited by others 2    

Recommend this journal